MedImmune says swine flu vaccine ready end-Sept
WASHINGTON (Reuters) - MedImmune's inhaled vaccine against the pandemic H1N1 virus could be ready to start shipping to the U.S. government by the end of September, a company official said on Thursday.
MedImmune's Dr. Raburn Mallory said the company, a unit of AstraZeneca, has submitted safety data for their nasal spray swine flu vaccine to the U.S. Food and Drug Administration.
"There are no red flags there. We think we can have 5 million doses ready to distribute at the end of September," Mallory said in an interview. U.S. officials had not expected vaccination to begin until mid-October.
(Editing by Sandra Maler)
- Tweet this
- Share this
- Digg this
- Google launches $105 Android One; eyes low-price smartphone boom
- Pakistani Islamists use floods to turn opinion against India
- Boeing, SpaceX win contracts to build 'space taxis' for NASA |
- Iraqi official briefs Syria's Assad on efforts against Islamic State
- Citing security threat, Obama expands U.S. role fighting Ebola
The United States has pledged to send 3,000 troops West Africa, using its military muscle to battle the biggest ever outbreak of the deadly Ebola virus, with an unprecedented mission to build treatment clinics and train health workers. Full Article